Topic
Biotech
245 published works
The Right Coast
Frontiers | Organoid intelligence (OI): the new frontier in biocomputing and intelligence-in-a-dish
Biological computing (or biocomputing) could be faster, more efficient, and more powerful than silicon-based computing and AI, and only require a fraction of the energy. Organoid intelligence (OI) describes an…
The Continuum of Risk
Azim Chowdhury, Neelam Gill, and Josephine Hsu Awarded 2022 “Go-To Thought Leader” Distinction by The National Law Review
Keller and Heckman Partner Azim Chowdhury, Counsel Neelam Gill, and Associate Josephine Hsu received the 2022 “Go-To Thought Leader” award from the National Law Review under the “Biotech, Food and…
The Daily Intake
<strong>Office of Science and Technology Policy Requests Public Input on Biotechnology Regulation</strong>
The Office of Science and Technology Policy (OSTP) issued a request for information (RFI) today in which it invites public comment on the Coordinated Framework for the Regulation of Biotechnology…
Gadgets, Gigabytes & Goodwill Blog
Technologies for Enhancing Cannabis Bioavailability and Their Legal Methods of Protection
Co-authored by Ruth Fisher, PhD The following post explores the bioavailability and efficacy of various cannabis products, followed by a brief overview of the legal protection afforded to each as an…
Nano and Other Emerging Chemical Technologies Blog
USDA Scientists Produce Nanobodies in Plant Cells that Block Emerging Pathogens
By Carla N. Hutton, Lynn L. Bergeson
On November 30, 2022, the U.S. Department of Agriculture’s (USDA) Agricultural Research Service (ARS) announced that its scientists have determined that plants could be used to produce nanobodies that quickly…
Agricultural Law Weekly Review
Agricultural Law Weekly Review—Week Ending November 25, 2022
Biotechnology: USDA Secretary Releases Statement on U.S.-Mexico Corn Trade After Meeting with Mexican President On November 28, 2022, the U.S. Department of Agriculture (USDA) Foreign Agriculture Service (FAS) published a…
Biosimilars Law Bulletin
<i>Amgen v. Sanofi</i> Case on Enablement of Antibody Genus Claims Will be Heard at the Supreme Court; <i>Cert</i> Denied in <i>Juno v. Kite</i>
By Jennifer P. Nock, Malissa Magiera
The Supreme Court agreed on Friday, November 4, 2022, to review the standard for enablement of genus claims after the Federal Circuit’s decision in Amgen, Inc. v. Sanofi. We have…
Health Law Prof Blog
Human Germline Editing and a Christian View of Human Nature
Jeffrey A. Brauch (Regent University), Human Germline Editing and a Christian View of Human Nature, SSRN (2022):Rapid developments in biotechnology now permit researchers to edit the DNA of human embryos.…
The Healthcare Investor
Healthcare & Life Sciences Private Equity Deal Tracker: Great Point Invests in iXCells Biotechnologies
Great Point Partners (GPP) has completed a growth investment in iXCells Biotechnologies, according to a news release. iXCells, based in San Diego, is a provider of cell-based products and discovery…
Israel Global Gateway
Bioeconomy Executive Order: A whole-of-government approach to advancing biotechnology and biomanufacturing
By Israel Group
President Joe Biden has issued an Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy (EO) that will likely have impacts on the pharmaceutical, energy,…